Search results for ‘manufacturing’
288 items found
-
Foreign demand for UK goods contracts for 14th month in a row
Foreign demand for UK manufactured goods has contracted for the 14th month in a row, according to the latest Purchasing Managers Index published this morning. Falling new export orders in March are “a significant drain on demand” according to Rob Dobson of S&P Global Intelligence, who put together the survey, “offsetting signs of a modest…
-
9m
Turkey’s Erdogan admits problems with earthquake emergency response
President Erdogan has acknowledged that initially there were problems with Turkey’s emergency response and has promised to rehouse people left without homes within a year.
-
Why is Germany turning back to coal for energy?
As climate activists in Germany occupy the village of Lützerath to protest the expansion of a coal mine, politicians and the public are posed a question by the dirtiest fossil fuel: is it OK to use more coal now, if it means you can more quickly decarbonise later?
-
Exclusive: Dyson faces legal action over ‘forced labour’ and exploitation
More than a dozen workers making products and components for Dyson are taking legal action against the company, alleging a string of labour abuses at a supplier in Malaysia, a Channel 4 News investigation can reveal.
-
1m
Industry leaders seek urgent action from government on rising energy prices
Leaders from industries most affected by the surging gas prices have been meeting the business secretary today, calling on the government to take urgent action.
-
2m
Can high-wage economy be delivered?
Faced with an economy battered by the pandemic and an uncertain future, is that kind of rosy confidence realistic?
-
4m
UK has only 5-15 days left of CO2 for meat production in worst case scenario, says British Meat Processors Association
How serious are the warnings of imminent shortages? Nick Allen, chief executive of the British Meat Producers Association spoke to us.
-
3m
Rishi Sunak sets out vision for UK economy in Mansion House speech
While the prime minister was welcoming Nissan’s investment in manufacturing, the chancellor was setting out what he called an “exciting future” for another key part of the economy. Rishi Sunak’s Mansion House speech was full of pr
-
ExxonMobil lobbyist reveals company’s involvement with ‘forever chemicals’
A senior ExxonMobil lobbyist, captured on camera by Greenpeace UK’s Unearthed, has claimed that the company “manufactures” and “uses” controversial so-called “forever chemicals” and is working to delay a ban on their use.
-
2m
India battles Covid second wave as oxygen becomes scarce
It is home to the biggest Covid-19 vaccine manufacturing facility in the world, but that has not saved India from a deadly second wave that threatens to overwhelm hospitals and crematoria.
-
FactCheck: What is happening with Britain’s vaccine supply?
AstraZeneca has committed to delivering 2 million doses of vaccine a week, but it’s not easy to check whether this benchmark is being hit.
-
6m
Storm Christoph brings heavy snowfall and floods to parts of UK
Torrential rain, severe flooding, hundreds of people forced from their homes – the reality of our climate crisis as Storm Christoph hits large parts of the country. There’s been heavy snow in Scotland and flood alerts across swathes of north west England and Wales. Emergency crews worked through the night to prevent flood damage at…
-
FactCheck Q&A: are we on track to hit vaccination targets?
Ministers have insisted the UK is on track to hit a target of offering a Covid-19 vaccine to almost 14 million people by the middle of next month. But questions remain about the supply of vaccines.
-
FactCheck Q&A: how much coronavirus vaccine do we have?
All the evidence suggests the number of vaccine doses available for immediate use falls well short of the 40 million that we were originally supposed to have by this stage.
-
FactCheck Q&A: how safe is the Oxford Covid-19 vaccine?
The coronavirus vaccine developed by Oxford University is under scrutiny after the makers admitted an error had led to different groups getting different doses in clinical trials.